| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zai Lab Limited (ZLAB) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 76 sells. ZLAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.12M | $20.75M | - | |
| Other | 117.6K | $2.17M | - | |
| Other | 57.0K | $1.05M | - | |
| CFO | 31.7K | $585.9K | - | |
| Other | 23.4K | $431.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | Du Ying79 | Chairwoman &CEO | Sale+OE | 111,111 | $176.30 | $19,589,250.49 | -0.7% | -18.3% | -83.8% | |
| Jun 2, 2021 | Cho William Ki Chul | Chief Financial Officer | Sell | 10,000 | $180.20 | $1,802,007.12 | -9.0% | -18.3% | -83.8% | |
| May 26, 2021 | Fu Tao90 | President &COO | Sale+OE | 10,000 | $159.40 | $1,594,036.43 | -1.2% | -12.0% | -81.8% | |
| May 25, 2021 | Reinhart Harald80 | Chief Medical Officer | Sale+OE | 16,000 | $162.02 | $2,592,240.00 | -100% | -8.1% | -79.6% | |
| May 5, 2021 | Diekman John D77 | Director | Sell | 1,000 | $153.62 | $153,620.00 | -1.6% | -2.6% | -76.4% | |
| May 4, 2021 | Du Ying79 | Chairwoman &CEO | Sell | 111,111 | $160.05 | $17,782,975.81 | -0.5% | -7.1% | -75.9% | |
| Apr 21, 2021 | Reinhart Harald80 | Chief Medical Officer | Sale+OE | 16,000 | $156.10 | $2,497,520.00 | -100% | +2.6% | -73.2% | |
| Apr 19, 2021 | Fu Tao90 | President &COO | Sale+OE | 10,000 | $162.91 | $1,629,140.00 | -1.6% | -6.3% | -72.5% | |
| Apr 7, 2021 | Du Ying79 | Chairwoman &CEO | Sell | 111,112 | $128.19 | $14,243,681.94 | -0.6% | +22.1% | -65.5% | |
| Mar 12, 2021 | Chen Kai-Xian | Director | Sell | 4,302 | $142.53 | $613,164.06 | -14.9% | +21.5% | -79.1% |